Lin JH - Search Results

1

Complexities of glucuronidation affecting in vitro in vivo extrapolation.

Lin JH, Wong BK. Lin JH, et al. Curr Drug Metab. 2002 Dec;3(6):623-46. doi: 10.2174/1389200023336992. Curr Drug Metab. 2002. PMID: 12369890 Review.

2

Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein.

Hochman JH, Yamazaki M, Ohe T, Lin JH. Hochman JH, et al. Among authors: lin jh. Curr Drug Metab. 2002 Jun;3(3):257-73. doi: 10.2174/1389200023337559. Curr Drug Metab. 2002. PMID: 12083320 Review.

3

A combinatorial library of indinavir analogues and its in vitro and in vivo studies.

Cheng Y, Rano TA, Huening TT, Zhang F, Lu Z, Schleif WA, Gabryelski L, Olsen DB, Stahlhut M, Kuo LC, Lin JH, Xu X, Jin L, Olah TV, McLoughlin DA, King RC, Chapman KT, Tata JR. Cheng Y, et al. Among authors: lin jh. Bioorg Med Chem Lett. 2002 Feb 25;12(4):529-32. doi: 10.1016/s0960-894x(01)00824-1. Bioorg Med Chem Lett. 2002. PMID: 11844665

4

Mechanistic studies on metabolic interactions between gemfibrozil and statins.

Prueksaritanont T, Zhao JJ, Ma B, Roadcap BA, Tang C, Qiu Y, Liu L, Lin JH, Pearson PG, Baillie TA. Prueksaritanont T, et al. Among authors: lin jh. J Pharmacol Exp Ther. 2002 Jun;301(3):1042-51. doi: 10.1124/jpet.301.3.1042. J Pharmacol Exp Ther. 2002. PMID: 12023536

5

Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapy.

Lin JH. Lin JH. Curr Drug Metab. 2007 Feb;8(2):109-36. doi: 10.2174/138920007779816002. Curr Drug Metab. 2007. PMID: 17305491 Review.

6

Transporter-mediated drug interactions: clinical implications and in vitro assessment.

Lin JH. Lin JH. Expert Opin Drug Metab Toxicol. 2007 Feb;3(1):81-92. doi: 10.1517/17425255.3.1.81. Expert Opin Drug Metab Toxicol. 2007. PMID: 17269896 Review.

7

In vitro and in vivo CYP3A64 induction and inhibition studies in rhesus monkeys: a preclinical approach for CYP3A-mediated drug interaction studies.

Prueksaritanont T, Kuo Y, Tang C, Li C, Qiu Y, Lu B, Strong-Basalyga K, Richards K, Carr B, Lin JH. Prueksaritanont T, et al. Among authors: lin jh. Drug Metab Dispos. 2006 Sep;34(9):1546-55. doi: 10.1124/dmd.106.009878. Epub 2006 Jun 16. Drug Metab Dispos. 2006. PMID: 16782766

8

CYP induction-mediated drug interactions: in vitro assessment and clinical implications.

Lin JH. Lin JH. Pharm Res. 2006 Jun;23(6):1089-116. doi: 10.1007/s11095-006-0277-7. Epub 2006 May 26. Pharm Res. 2006. PMID: 16718615 Review.

9

Interconversion pharmacokinetics of simvastatin and its hydroxy acid in dogs: effects of gemfibrozil.

Prueksaritanont T, Qiu Y, Mu L, Michel K, Brunner J, Richards KM, Lin JH. Prueksaritanont T, et al. Among authors: lin jh. Pharm Res. 2005 Jul;22(7):1101-9. doi: 10.1007/s11095-005-6037-2. Epub 2005 Jul 22. Pharm Res. 2005. PMID: 16028010

10

Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: role of CYP3A and P-glycoprotein.

Kumar S, Kwei GY, Poon GK, Iliff SA, Wang Y, Chen Q, Franklin RB, Didolkar V, Wang RW, Yamazaki M, Chiu SH, Lin JH, Pearson PG, Baillie TA. Kumar S, et al. Among authors: lin jh. J Pharmacol Exp Ther. 2003 Mar;304(3):1161-71. doi: 10.1124/jpet.102.045096. J Pharmacol Exp Ther. 2003. PMID: 12604693

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results